As HIV treatment evolves and simplified treatment regimens become more common, understanding the implications of viral hepatitis co-infection is increasingly important. This webinar will provide a practical update on hepatitis B, hepatitis D and hepatitis C in people living with HIV, with a particular focus on treatment decision-making and avoiding unintended consequences when modifying antiretroviral therapy.
Drawing on recent clinical evidence and case studies, the session will explore hepatitis B reactivation risks, considerations when switching from tenofovir-containing regimens, and best-practice approaches to managing viral hepatitis co-infections in primary care and specialist settings.
Date, Time, Platform:
- Date: Thursday 26 November 2026
- Time: 6:00pm – 7:00pm (AWST)
- Platform: Live Online – Zoom
Speakers:
- Adam Gregson-Day | Nurse Practitioner | Royal Perth Hospital
CPD and Endorsement:
Endorsement is currently pending with RACGP and ACRRM. This activity may be suitable for self-claiming CPD hours with your professional body. An estimated equivalent of 1 CPD hours applies. A statement of attendance will be provided for full attendees.
Accredited HIV Prescribers attending in full will also receive 2 HIV Prescriber Points.
Funding:
This activity is funded by Western Australian Department of health.
Target Audience:
HIV and HBV s100 prescribers based in WA.
